Form 4: Hims & Hers Health Executive Exercises and Sells Stock Options Under 10b5-1 Plan

Michael Chi, Chief Commercial Officer of Hims & Hers Health, Inc., executed stock option exercises and sales under a pre-arranged Rule 10b5-1 trading plan.

Summary

• Michael Chi, the Chief Commercial Officer of Hims & Hers Health, Inc., reported transactions involving Class A Common Stock.
• On January 21, 2025, Chi exercised stock options to acquire 306 shares at a price of $13.90 per share.
• Simultaneously, Chi sold 306 shares of Class A Common Stock at a price of $28.68 per share.
• These transactions were executed under a Rule 10b5-1 trading plan adopted on March 1, 2024.
• Following these transactions, Chi directly owns 193,601 shares of Class A Common Stock and 51,276 stock options.

Sentiment

Score: 5

Explanation: This is a neutral disclosure of stock transactions. It doesn't inherently indicate positive or negative sentiment about the company's performance.

Industry Context

This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. The use of a 10b5-1 plan suggests that the transactions were pre-planned and not based on any inside information.

Comparison to Industry Standards

• Executive stock option exercises and sales are a common practice in publicly traded companies, particularly in the tech and healthcare sectors where Hims & Hers operates.
• Companies like Teladoc Health and GoodRx also see similar filings from their executives.
• The use of Rule 10b5-1 plans is a standard practice to avoid accusations of insider trading.

Stakeholder Impact

• The transactions have a minimal direct impact on shareholders, employees, customers, suppliers, and creditors.
• The sale of shares by an executive could be perceived negatively by some investors, but the existence of a 10b5-1 plan mitigates this concern.

Key Dates

Keywords

Form 4, Hims & Hers Health, Michael Chi, Stock Options, Rule 10b5-1, Insider Trading, Executive Compensation, Securities Exchange Act